Anti-heart autoantibodies in familial dilated cardiomyopathy

References

• Karkkainen S, Peuhkurinen K. Genetics of dilated cardiomyopathy. Ann Med 2007; 39: 91–107
   PubMed Web of Science ®Google Scholar
• MacLellan RW, Lusis AJ. Dilated cardiomyopathy: Learning to live with yourself. Nat Med 2003; 9: 1455–1456
   PubMed Web of Science ®Google Scholar
• Okazaki T, Tanaka Y, Nishio R, et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med 2003; 9: 1477–1483
   PubMed Web of Science ®Google Scholar
• Eriksson U, Ricci R, Hunziker L, et al. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 2003; 9: 1484–1490
   PubMed Web of Science ®Google Scholar
• Richardson P, McKenna WJ, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996; 93: 841–842
   PubMed Web of Science ®Google Scholar
• Caforio ALP, McKenna WJ. Recognition and optimum treatment of myocarditis. Drugs 1996; 52: 515–525
   PubMed Web of Science ®Google Scholar
• Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of cardiomyopathies. An American Heart Association Scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; quality of Care and Outcome research and Functional Genomics and Translational Biology Interdisciplinary Working Groups: and Council on Epidemiology and Prevention. Circulation 2006; 113: 1807–1816
   Google Scholar
• Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: A position statement from the European Society of Cardiology working group on myocardial and pericardial disease. Eur Heart J 2007, online pub October 4, doi: 10.1093/eurheartj/ehm342
   Google Scholar
• Pauschinger M, Noutsias M, Lassner D, et al. Inflammation ECG Whom to biopsy in suspected myocarditis?. Clin Res Cardiol 2006; 95: 569–583
   PubMed Web of Science ®Google Scholar
• Magnani JW, Dec WG. Myocarditis. Current trends in diagnosis and treatment. Circulation 2006; 113: 876–890
   PubMed Web of Science ®Google Scholar
• Caforio ALP, Calabrese F, Angelini A, et al. A prospective study of biopsy-proven myocarditis: Prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 2007; 28: 1326–1333
   PubMed Web of Science ®Google Scholar
• Marin-Neto JA, Cuhna-Neto E, Maciel BC, Simoes MV. Pathogenesis of chronic Chagas heart disease. Circulation 2007; 115: 1109–1123
   PubMed Web of Science ®Google Scholar
• Maekawa Y, Ouzounian M, Opavsky A, Liu PP. Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton and innate immunity. Circulation 2007; 115: 5–8
   PubMed Web of Science ®Google Scholar
• Li Y, Heuser JS, Cunningham LC, et al. Mimicry and antibody-mediated cell signalling in autoimmune myocarditis. J Immunol 2006; 177: 8234–8240
   PubMed Web of Science ®Google Scholar
• Rose NR. Viral damage or ‘molecular mimicry’-placing the blame in myocarditis. Nat Med 2000; 6: 631–632
   PubMed Web of Science ®Google Scholar
• Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993; 14: 426–428
   PubMedGoogle Scholar
• Aretz HT, Billingham ME, Edwards WE, et al. Myocarditis: A histopathologic definition and classification. Am J Cardiol Pathol 1985; 1: 1–10
   Google Scholar
• The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and shared controls. Nature 2007; 447: 661–683
   PubMed Web of Science ®Google Scholar
• The International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357: 1–12
   PubMed Web of Science ®Google Scholar
• Todd JA, Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007; 39: 857–864
   PubMed Web of Science ®Google Scholar
• Lowe CE, Cooper JD, Brusko T, et al. Large-scale genetic fine mapping and genotype-phenotype associations implicate a polymorphism in the IL2RA region in Type 1 diabetes. Nat Genet 2007; 39: 1074–1082
   PubMed Web of Science ®Google Scholar
• Nejentsev S, Howson JMM, Walker NM, et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007, doi:101038/nature06406
   PubMed Web of Science ®Google Scholar
• Lamparter S, Pankuweit S, Maisch B. Clinical and immunological characteristics in peripartum cardiomyopathy. Int J Cardiol 2007; 118: 14–20
   PubMed Web of Science ®Google Scholar
• Portig I, Wilke A, Freyland M, et al. Familial inflammatory dilated cardiomyopathy. Eur J Heart Fail 2006; 8: 816–825
   PubMed Web of Science ®Google Scholar
• Mestroni L, Rocco C, Gregori D, et al. Familial dilated cardiomyopathy:evidence for genetic and phenotypic heterogeneity. J Am Coll Cardiol 1999; 34: 181–190
   PubMed Web of Science ®Google Scholar
• Basso C, Thiene G, Corrado D, et al. Arrhythmogenic right ventricular cardiomyopathy: Dysplasia, dystrophy or myocarditis?. Circulation 1996; 94: 983–991
   PubMed Web of Science ®Google Scholar
• Frustaci A, Verardo R, Caldarulo M, et al. Myocarditis in hypertrophic cardiomyopathy patients presenting acute clinical deterioration. Eur Heart J 2007; 28: 733–740
   PubMed Web of Science ®Google Scholar
• Frustaci A, Priori SG, Pieroni M, et al. Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation 2005; 112: 3680–3687
   PubMed Web of Science ®Google Scholar
• Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol. Nov 2007; 6;50(19)1914–1931
   Google Scholar
• Skouri HN, Dec W, Friedrich MG, et al. Noninvasive imaging in myocarditis. J Am Coll Cardiol 2006; 114: 1581–1590
   Google Scholar
• Mahrholdt H, Wagner A, Deluigi CC, et al. Presentations, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006; 114: 1581–1590
   PubMed Web of Science ®Google Scholar
• Caforio ALP, Stewart JT, Bonifacio E, et al. Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity?. J Autoimmun 1990; 3: 187–200
   PubMed Web of Science ®Google Scholar
• Mahon NG, Madden B, Caforio ALP, et al. Immunohistochemical evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. J Am Coll Cardiol 2002; 39: 455–462
   PubMed Web of Science ®Google Scholar
• Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al. Randomized, placebo controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy. Two-year follow-up results. Circulation 2001; 104: 39–45
   PubMed Web of Science ®Google Scholar
• Mahon NG, Murphy RT, MacRae C, Caforio ALP, Elliott PM, McKenna WJ. Echocardiographic evaluation in asymptomatic relatives of dilated cardiomyopathy patients reveals preclinical disease. Ann Intern Med 2005; 143: 108–115
   PubMed Web of Science ®Google Scholar
• Caforio ALP, Keeling PJ, Zachara E, et al. Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet 1994; 344: 773–777
   PubMed Web of Science ®Google Scholar
• Caforio ALP, Mahon NG, Baig KM, et al. Prospective familial assessment in dilated cardiomyopathy. Cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation 2007; 115: 76–83
   PubMed Web of Science ®Google Scholar
• Anderson JL, Carlquist JF, Lutz JR, et al. HLA A, B, and DR typing in idiopathic dilated cardiomyopathy: a search for immune response factors. Am J Cardiol 1984; 53: 1326–1330
   PubMed Web of Science ®Google Scholar
• Fletcher GF, Wenger NK. Autoimmune studies in patients with primary myocardial disease. Circulation 1968; 37: 1032–1035
   PubMed Web of Science ®Google Scholar
• Camp FT, Hess EV, Conway G, et al. Immunologic findings in idiopathic cardiomyopathy. Am Heart J 1969; 77: 610–615
   PubMed Web of Science ®Google Scholar
• Kirsner AB, Hess EV, Fowler NO. Immunologic findings in idiopathic cardiomyopathy: A prospective serial study. Am Heart Journal 1973; 86: 625–630
   PubMed Web of Science ®Google Scholar
• Maisch B, Deeg P, Liebau G, et al. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol 1983; 52: 1071–1078
   Web of Science ®Google Scholar
• Maisch B, Deeg P, Liebau G, et al. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with viral myocarditis. Clin Exp Immun 1983; 48: 533–545
   Web of Science ®Google Scholar
• Neumann DA, Burek CL, Baughman KL, et al. Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol 1990; 16: 839–846
   PubMedGoogle Scholar
• Caforio ALP, Bonifacio E, Stewart JT, et al. Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol 1990; 15: 1527–1534
   PubMed Web of Science ®Google Scholar
• Caforio ALP, Wagner R, Gill JS, et al. Organ-specific cardiac antibodies: Serological markers for systemic hypertension in autoimmune polyendocrinopathy. Lancet 1991; 337: 1111–1115
   PubMed Web of Science ®Google Scholar
• Caforio ALP, Goldman JH, Haven AJ, et al. Circulating cardiac autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis. Eur Heart J 1997; 18: 270–275
   PubMed Web of Science ®Google Scholar
• Caforio ALP, Grazzini M, Mann JM, et al. Identification of α and β cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992; 85: 1734–1742
   PubMed Web of Science ®Google Scholar
• Lauer B, Schannwell M, Kuhl U, et al. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol 2000; 35: 11–18
   PubMed Web of Science ®Google Scholar
• Latif N, Baker CS, Dunn MJ, et al. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and Western blotting. J Am Coll Cardiol 1993; 22: 1378–1384
   PubMed Web of Science ®Google Scholar
• Goldman JH, Keeling PJ, Warraich RS, et al. Autoimmunity to α-myosin in a subset of patients with idiopathic dilated cardiomyopathy. Br Heart J 1995; 74: 598–603
   PubMedGoogle Scholar
• Michels VV, Moll PP, Rodeheffer RJ, et al. Circulating heart autoantibodies in familial as compared with nonfamilial idiopathic dilated cardiomyopathy. Mayo Clin Proc 1994; 69: 24–27
   PubMed Web of Science ®Google Scholar
• Konstandoulakis MM, Kroumbouzou H, Tsiamis E, Trikas A, Toutouzas P. Clinical significance of antibodies against tropomyosin, actin and myosin in patients with dilated cardiomyopathy. J Clin Lab Immunol 1993; 40: 61–67
   PubMedGoogle Scholar
• Warraich RS, Dunn MJ, Yacoub MH. Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: Proinflammatory antibodies in dilated cardiomyopathy patients. Biochem Biophys Res Commun 1999; 259: 255–261
   PubMed Web of Science ®Google Scholar
• Portig I, Pankuweit S, Maisch B. Antibodies against stress proteins in sera of patients with dilated cardomyopathy. J Mol Cell Cardiol 1997; 29: 2245–2251
   PubMed Web of Science ®Google Scholar
• Latif N, Smith J, Dunn MJ, et al. Complement-mediated cytotoxic activity of anti-heart antibodies present in the sera of patients with dilated cardiomyopathy. Autoimmunity 1994; 19: 99–104
   PubMed Web of Science ®Google Scholar
• Staudt A, Eichler P, Trimpert C, et al. Fcγ receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy. J Am Coll Cardiol 2007; 49: 1684–1692
   PubMed Web of Science ®Google Scholar
• Baba A, Yoshikawa T, Ogawa S. Autoantibodies against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy. J Am Coll Cardiol 2002; 40: 1153–1159
   PubMed Web of Science ®Google Scholar
• Wolff PG, Kuhl U, Schultheiss HP. Laminin distribution and autoantibodies to laminin in dilated cardiomyopathy and myocarditis. Am Heart J 1989; 117: 1303–1309
   PubMed Web of Science ®Google Scholar
• Klein R, Maisch B, Kochsiek K, et al. Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases. Clin Exp Immunol 1984; 58: 283–292
   PubMed Web of Science ®Google Scholar
• Otto A, Stahle I, Klein R, et al. Anti-mitochondrial antibodies in patients with dilated cardiomyopathy (anti-M7) are directed against flavoenzymes with covalently bound FAD. Clin Exp Immunol 1998; 111: 541–547
   PubMed Web of Science ®Google Scholar
• Schultheiss HP, Bolte HD. Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol 1985; 17: 603–617
   PubMed Web of Science ®Google Scholar
• Schultheiss HP, Kuhl U, Schwimmbeck P, . Biomolecular changes in dilated cardiomyopathy. Advances in Cardiomyopathies, G Baroldi, F Camerini, JF Goodwin, et al. Springer Verlag, Berlin 1990; 221–234
   Google Scholar
• Ansari AA, Neckelmann N, Villinger F, et al. Epitope mapping of the branched chain α- ketoacid dehydrogenase dihydrolipoyl transacylase (BCKD-E2) protein that reacts with sera from patients with idiopathic dilated cardiomyopathy. J Immunol 1994; 153: 4754–4765
   PubMed Web of Science ®Google Scholar
• Pohlner K, Portig I, Pankuweit S, et al. Identification of mitochondrial antigens recognized by antibodies in sera of patients with idiopathic dilated cardiomyopathy by two-dimensional gel electrophoresis and protein sequencing. Am J Cardiol 1997; 80: 1040–1045
   PubMed Web of Science ®Google Scholar
• Schultheiss HP, Ulrich G, Janda I, et al. Antibody mediated enhancement of calcium permeability in cardiac myocytes. J Exp Med 1988; 168: 2105–2119
   PubMed Web of Science ®Google Scholar
• Wallukat G, Morwinski M, Kowal K, et al. Antibodies against the β-adrenergic receptor in human myocarditis and dilated cardiomyopathy: β-Adrenergic agonism without desensitization. Eur Heart J 1991; 12(Suppl D)178–181
   PubMed Web of Science ®Google Scholar
• Limas CJ. Limas C. β-Receptor antibodies and genetics in dilated cardiomyopathy. Eur Heart J, 12((Suppl D))175–177
   PubMedGoogle Scholar
• Magnusson Y, Wallukat G, Waagstein F, et al. Autoimmunity in idiopathic dilated cardiomyopathy: Characterization of antibodies against the β1-adrenoceptor with positive chronotropic effect. Circulation 1994; 89: 2760–2767
   PubMed Web of Science ®Google Scholar
• Jahns R, Boivin V, Siegmund C, et al. Autoantibodies activating human β1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 1999; 99: 649–654
   PubMed Web of Science ®Google Scholar
• Jahns R, Boivin V, Krapf T, et al. Modulation of β1-adrenoceptor activity by domain-specific antibodies and heart-failure associated autoantibodies. J Am Coll Cardiol 2000; 36: 1280–1287
   PubMed Web of Science ®Google Scholar
• Fu LX, Magnusson Y, Bergh CH, et al. Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1993; 91: 1964–1968
   PubMed Web of Science ®Google Scholar
• Marriott JB, Goldman JH, Keeling PJ, Baig MK, Dalgleish AG, McKenna WJ. Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relatives. Heart 1996; 75: 287–290
   PubMed Web of Science ®Google Scholar
• Kuan AP, Zuckier L, Liao L, et al. Immunoglobulin isotype determines pathogenicity in antibody-mediated myocarditis in naïve mice. Circ Res 2000; 86: 281–285
   PubMed Web of Science ®Google Scholar
• Neu N, Rose NR, Beisel KW, et al. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987; 139: 3630–3636
   PubMed Web of Science ®Google Scholar
• Smith SC, Allen PM. Myosin-induced myocarditis is a T cell-mediated disease. J Immunol 1991; 147: 2141–2147
   PubMed Web of Science ®Google Scholar
• Elliott JF, Liu J, Yuan ZN, et al. Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAbeta knockout NOD mice. PNAS 2003; 100: 13447–13452
   PubMed Web of Science ®Google Scholar
• Taylor JA, Havari E, McInerney MF, et al. A spontaneous model for autoimmune myocarditis using the human MHC HLA-DQ8. J Immunol 2004; 172: 2651–2658
   PubMed Web of Science ®Google Scholar
• Hayward SL, Lopez-Bautista N, Suzuki K, et al. CD4 T cells play major effector role and CD8 T cells initiating role in spontaneous autoimmune myocarditis of HLA-DQ8 transgenic Iab knockout nonobese diabetic mice. J Immunol 2006; 176: 7715–7725
   PubMed Web of Science ®Google Scholar
• Taneja V, Behrens M, Cooper LT, et al. Spontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic mice. J Mol Cell Cardiol 2007; 42: 1054–1064
   PubMed Web of Science ®Google Scholar
• Guler ML, Ligons DL, Wang Y, et al. Two autoimmune diabetes loci influencing T cell apoptosis control susceptibility to experimental autoimmune myocarditis. J Immunol 2005; 174: 2167–2173
   PubMed Web of Science ®Google Scholar
• Ono M, Shimizu J, Miyachi Y, Sakaguchi S. Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family related protein high, Foxp3-expressing CD25+ and CD25 - regulatory T cells. J Immunol 2006; 176: 4748–4756
   PubMed Web of Science ®Google Scholar
• Jane-wit D, Altuntas CZ, Johnson JM, et al. β1-Adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis. Circulation 2007; 116: 399–410
   PubMed Web of Science ®Google Scholar
• Mao W, Fukuoka S, Iwai C, et al. Cardiomyocyte apoptosis in autoimmune cardiomyopathy:mediated via endoplasmic reticulum stress and exaggerated by noepinephrine. Am J Physiol Heart Circ Physiol 2007; 293: H1636–H1645
   PubMed Web of Science ®Google Scholar
• Nishimura H, Okazaki T, Tanaka Y, et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001; 291: 319–322
   PubMed Web of Science ®Google Scholar
• Caforio ALP, Tona F, Bottaro S, et al. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity 2008; 41(1)35–45
   PubMed Web of Science ®Google Scholar
• Mrena S, Savola K, Kulmala P, et al. Genetic modification of risk assessment based on staging of preclinical Type 1 diabetes in siblings of affected children. J Clin Endocrinol Metab 2003; 88: 2682–2689
   PubMed Web of Science ®Google Scholar
• Warraich RS, Griffiths E, Falconar A, et al. Human cardiac myosin autoantibodies impair myocyte contractility: A cause-and-effect relationship. FASEB J 2006; 20: 651–660
   PubMed Web of Science ®Google Scholar
• Mobini R, Staudt A, Felix SB, et al. Hemodynamic improvement and removal of autoantibodies against the β1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy. J Autoimmun 2003; 20: 345–350
   PubMed Web of Science ®Google Scholar
• Urayama O, Shutt H, Sweadner J. Identification of three isozyme proteins of the catalytic subunit of the Na,K-ATPase in rat brain. J Biol Chem 1989; 264: 8271–8280
   PubMed Web of Science ®Google Scholar
• Jahns R, Boivin V, Hein L, et al. Direct evidence for a β1-adrenergic receptor directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 2004; 113: 1419–1429
   PubMed Web of Science ®Google Scholar
• Nikolaev VO, Boivin V, Stork S, et al. A novel fluorescence method for the rapid detection of functional β1-adrenergic receptor autoantibodies in heart failure. J Am Coll Cardiol 2007; 50: 423–431
   PubMed Web of Science ®Google Scholar
• Jahns R, Boivin V, Lohse MJ, et al. β1-Adrenergic receptor function, autoimmunity and pathogenesis of dilated cardiomyopathy. Trends Cardiovasc Med 2006; 16: 20–24
   PubMed Web of Science ®Google Scholar
• Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A. Immunosuppressive therapy for active lymphocytic myocarditis: Virological and immunologic profile of responders versus nonresponders. Circulation 2003; 107: 857–863
   PubMed Web of Science ®Google Scholar
• Ashrafian H, Watkins H. Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications. Cardiomyopathies therapeutics based on molecular phenotype. J Am Coll Cardiol 2007; 49: 1251–1264
   PubMed Web of Science ®Google Scholar